* Neuronetics Inc STIM.OQ reported a quarterly adjusted
loss
of 27 cents per share for the quarter ended in March, higher
than the same quarter last year, when the company reported EPS
of -38 cents. The mean expectation of four analysts for the
quarter was for a loss of 31 cents per share. Wall Street
expected results to range from -37 cents to -26 cents per share.
* Revenue rose 12.1% to $17.42 million from a year ago;
analysts
expected $17.12 million.
* Neuronetics Inc's reported EPS for the quarter was a loss
of 27
cents.
* The company reported a quarterly loss of $7.87 million.
* Neuronetics Inc shares had fallen by 21.2% this
quarter and
gained 29.3% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 5.8%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* Wall Street's median 12-month price target for Neuronetics
Inc
is $7.00
This summary was machine generated from LSEG data May 7 at 02:23
p.m. UTC. All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.31 -0.27 Beat
Dec. 31 2023 -0.26 -0.19 Beat
Sep. 30 2023 -0.31 -0.33 Missed
Jun. 30 2023 -0.35 -0.17 Beat